De L. Zeng
No. 7 Raoping Road
Shantou, 515041, China
Shantou, 515041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Resistance mechanisms and post-trastuzumab deruxtecan (T-DXd) strategies in HER2+ and HER2-low breast cancer: From biology to clinical practice.
Journal: Critical reviews in oncology/hematology
Published: September 04, 2025
Cyclophosphamide for severe T-DXd-induced interstitial lung disease in low-HER2 breast cancer: a case report and mechanistic insights.
Journal: Frontiers in oncology
Published: May 30, 2025
Esophageal cancer trends in the US from 1992 to 2019 with projections to 2044 using SEER data.
Journal: Scientific reports
Published: March 05, 2025
Disulfidptosis, a novel regulated cell death to predict survival and therapeutic response in kidney renal clear cell carcinoma.
Journal: Discover oncology
Published: November 01, 2024
Endogenous retrovirus group FRD member 1 is a potential biomarker for prognosis and immunotherapy for kidney renal clear cell carcinoma.
Journal: Frontiers in cellular and infection microbiology
Published: July 04, 2023
RNA-binding proteins in breast cancer: Biological implications and therapeutic opportunities.
Journal: Critical reviews in oncology/hematology
Published: June 27, 2023
Prevalence and factors of COVID-19 vaccine refusal among solid cancer patients in China: an application of the health belief model.
Journal: Frontiers in public health
Published: June 07, 2023
Notch1 promotes resistance to cisplatin by up-regulating Ecto-5'-nucleotidase (CD73) in triple-negative breast cancer cells.
Journal: Cell death discovery
Published: April 25, 2023
Last Updated: 09/26/2026